It has been shown in BWS patients that aberrant methylation of KCNQ1OT1 is specifically associated with overgrowth and congenital defects, whereas aberrant methylation of H19 is specifically associated with an increased risk of developing tumors [16]. The gene discussed is H19; the disease is Beckwith-Wiedemann syndrome.